Trending
News
Plexus Ventures Appoints Pierfrancesco Maschio as Director for Southern Europe
Philadelphia, Pennsylvania – Plexus Ventures announces the appointment of Pierfrancesco Maschio, based in Milan, as Director for Southern Europe. Pierfrancesco is a long-time entrepreneur who has successfully built his Ricerchimica healthcare business development...
Plexus Ventures Assists Laboratorios Cinfa in Selling Biosimilar Business to Mundipharma
Philadelphia, Pennsylvania – Plexus Ventures is pleased to announce the successful conclusion of a divestiture project for its client, Laboratorios Cinfa, S.A. of Pamplona, Spain. Plexus Ventures advised Cinfa on the sale of its biosimilar business, Cinfa Biotech to a...
Mabion S.A. completes marketing authorization application for flagship drug, MabionCD20, to the European Medicines Agency (EMA)
Plexus Ventures would like to share successful news from Mabion S.A. Additional details are provided in Mabion’s press release (Konstantynów Łódzki, 1.06.2018): • Company submitted the marketing authorization application under the centralized authorization procedure...
Plexus Ventures Assists Fujifilm Kyowa Kirin Biologics in Partnering with Mylan of Humira® Biosimilar
Tokyo, Japan – Plexus Ventures is pleased to announce the successful conclusion of an out-licensing project of its client Fujifilm Kyowa Kirin Biologics Co., Ltd. Plexus Ventures provided professional services to Fujifilm Kyowa Kirin Biologics to partner the European...
Celon Pharma has positively concluded the decentralised procedure (DCP) for Salmex® on Scandinavian markets
Plexus Ventures would like to share successful news from Celon Pharma. Additional details are provided in Celon’s press release (Warsaw, 30.11.2017): • Finalisation of the DCP opens new perspectives for the Company in terms of export to the market as big as approx. 3...
Plexus Ventures Assists Celon Pharma SA with Development Strategy
Philadelphia, PA - Plexus Ventures, a global pharmaceutical consulting firm, announces its collaboration with Celon Pharma SA, Łomianki, Poland. Michael O’Sullivan Managing Partner London Office, noted: “We are very pleased to provide continuing support to an...
Plexus Ventures Assists Glenmark Pharmaceuticals to Divest a CNS Product Portfolio and Commercial Team in Poland to Neuraxpharm
Philadelphia, Pennsylvania – Plexus Ventures is pleased to announce the completion of a divestiture project on behalf of its client, Glenmark Pharmaceuticals Ltd. Plexus Ventures advised Glenmark on the sale of a CNS product portfolio and sales team to Neuraxpharm....
Olessia Kamp Joins Plexus Ventures as Senior Advisor in Germany
Philadelphia, Pennsylvania – Plexus Ventures announces the appointment of Olessia Kamp, based near Frankfurt, as Senior Advisor in Germany. Prior to joining Plexus, Olessia served for nearly 15 years at Berlin-Chemie AG, a subsidiary of Menarini, focusing from German...
How can we help you?
Plexus Ventures assists with M&A, divestments, licensing, strategic advice and consulting.
Subscribe to
Plexus News
Follow Us
Check out Plexus Ventures and other industry news shared daily.